Published on 29 Nov 2010
“ Improved collaboration accelerates our development time. ”
Diagnostic Grifols, a leading medical device provider, implementing an Agile solution to enhance collaboration throughout its product development cycle, sees significant results in time to market and regulation compliance.
The international scale of this company’s business calls for strict compliance of the software it uses to manage and control the development of its products. And the complexity of its development cycle requires software that can enhance teams’ collaboration to deliver products faster.
The solution connects all stages of the development cycle, allowing different developers working on the same project to build and share all regulated product data in a controlled environment. Through enhanced collaboration, teams have flexibility to adapt to changes in regulations and take action on potential conflict. By better anticipating schedules, teams keep investment and profitability on track. Automation of operations documentation allows the company to better support compliance audits.
• Time to market decreased by 20 percent • Error rates significantly reduced
IBM products and services that were used in this case study.
Rational Change, Rational DOORS, Rational Synergy
Continuous Engineering, IBM Analytics, Agile Software Development
© Copyright IBM Corporation 2013 IBM Corporation Software Group Route 100 Somers, NY 10589 Produced in the United States of America April 2013 IBM, the IBM logo, ibm.com, DOORS and Rational are trademarks of International Business Machines Corporation in the United States, other countries or both. If these and other IBM trademarked terms are marked on their first occurrence in this information with a trademark symbol (® or TM), these symbols indicate U.S. registered or common law trademarks owned by IBM at the time this information was published. Such trademarks may also be registered or common law trademarks in other countries. Other product, company or service names may be trademarks or service marks of others. A current list of IBM trademarks is available on the web at “Copyright and trademark information” at www.ibm.com/legal/copytrade.shtml. This document is current as of the initial date of publication and may be changed by IBM at any time. Not all offerings are available in every country in which IBM operates. The client examples cited are presented for illustrative purposes only. Actual performance results may vary depending on specific configurations and operating conditions. THE INFORMATION IN THIS Word documentUMENT IS PROVIDED “AS IS” WITHOUT ANY WARRANTY, EXPRESS OR IMPLIED, INCLUDING WITHOUT ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND ANY WARRANTY OR CONDITION OF NONINFRINGEMENT. IBM products are warranted according to the terms and conditions of the agreements under which they are provided.